Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC Standard-Dose Radiation Therapy Confirmed in Advanced NSCLC
Mature 5-year follow-up data from the RTOG 0617 trial confirm that a dose of 60 Gy is superior to 74 Gy in advanced inoperable non-small cell lung cancer (NSCLC).Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy